Priorix vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1W99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,399
Award facts
- Contract value 100% obligated
- $14,398.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,398.80 by the Defense Logistics Agency on January 23, 2026, for the supply of PRIORIX vials. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award based on open competition. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This overarching IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide.
The Defense Logistics Agency, operating under the Department of Defense, procures critical medical supplies for military treatment facilities, the Defense Health Agency, and other federal healthcare systems. PRIORIX is a combined measles, mumps, rubella, and varicella vaccine distributed through this contract vehicle to meet immunization requirements across the military health system. AmerisourceBergen's substantial contract portfolio and established relationship with DLA underscore its critical role as a federal medical supply vendor, with the company's delivery orders reflecting its versatility in fulfilling pharmaceutical procurement needs ranging from routine immunizations to specialized therapeutic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1W99?
SPE2DR26F1W99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F1W99 worth?
The government has obligated $14,399 on SPE2DR26F1W99.
Is contract SPE2DR26F1W99 an order under another contract?
Yes. SPE2DR26F1W99 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W99 competed?
The extent of competition for SPE2DR26F1W99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award